PAUL STEVEN M
SEC insider (Form 3/4/5 filer). CIK 0001237564. Director at Rapport Therapeutics, Inc. (RAPP) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Oct 22, 2026. Located in BOSTON, MA.
Companies PAUL STEVEN M has filed insider reports for
- Rapport Therapeutics, Inc. (RAPP): Director
- Seaport Therapeutics, Inc. (SPTX): Director
PAUL STEVEN M
CIK: 0001237564
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Oct 22, 2026RAPP
Rapport Therapeutics, Inc.
PurchaseIndirect35.7K shares at avg. $27.28$974K - Jun 10, 2026RAPP
Rapport Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
15.2K shares- - May 4, 2026SPTX
Seaport Therapeutics, Inc.
ConversionDirect67K shares- - Apr 30, 2026SPTX
Seaport Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
12.3K shares- - Apr 30, 2026SPTX
Seaport Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
991.2K shares- - Sep 12, 2025RAPP
Rapport Therapeutics, Inc.
PurchaseIndirect28.3K shares at avg. $24.50$693K - Sep 12, 2025RAPP
Rapport Therapeutics, Inc.
PurchaseIndirect13.4K shares at avg. $24.97$334K - Jun 17, 2025RAPP
Rapport Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
21.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 22, 2026 |  RAPP Rapport Therapeutics, Inc. | Purchase | 35,714 | $27.28 | $974,278 | Indirect |
| Jun 10, 2026 | RAPP Rapport Therapeutics, Inc. | Award Stock Option (Right to Buy) | 15,200 | - | - | Direct |
| May 4, 2026 |  SPTX Seaport Therapeutics, Inc. | Conversion | 67,031 | - | $0 | Direct |
| Apr 30, 2026 | SPTX Seaport Therapeutics, Inc. | Award Stock Option (Right to Buy) | 12,258 | - | - | Direct |
| Apr 30, 2026 | SPTX Seaport Therapeutics, Inc. | Award Stock Option (Right to Buy) | 991,192 | - | - | Direct |
| Sep 12, 2025 | RAPP Rapport Therapeutics, Inc. | Purchase | 28,284 | $24.50 | $692,947 | Indirect |
| Sep 12, 2025 | RAPP Rapport Therapeutics, Inc. | Purchase | 13,382 | $24.97 | $334,165 | Indirect |
| Jun 17, 2025 | RAPP Rapport Therapeutics, Inc. | Award Stock Option (Right to Buy) | 21,850 | - | - | Direct |
1-8 of 8 transactions